中芯(00981.HK)去年賺7.2億美元 今年上半年收入目標21億美元
中芯國際(00981.HK)首席財務官高永崗於業績報告中表示,2020年公司多項財務指標均創歷史新高。收入39.07億美元,增加25.4%;毛利9.21億美元,上升43.3%。錄得純利7.16億美元,增長205%。
展望2021全年,因被美國政府列入實體清單,公司在採購美國相關產品或技術時受到限制,給全年業績預期帶來了不確定風險。出口許可申請必須根據流程走,需要時間,也有一定的不確定性。基於此,我們全年收入目標為中到高個位數成長,上半年收入目標約21億美元;全年毛利率目標10%-20%的中部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.